Neoadjuvant therapy with Docetaxel (TAX) and Cisplatin (CIS) in patients (pts) with non-small cell lung cancer (NSCLC), stage IIIA, N2 is highly active with few toxicities
- 30 September 2000
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 29 (1) , 99
- https://doi.org/10.1016/s0169-5002(00)80325-6
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: